Buscar resultados de ensayos clínicos
Siderosis - 40 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Observation of Patients With Transfusional Hemosiderosis Treatment With Deferasirox Condición: Transfusional Hemosiderosis Fecha: 2011-07-12 Intervenciones: Drug: deferasirox Other Name: ICL670 |
Not yet recruiting |
Nombre del estudio: Efficacy of Bone Marrow Mesenchymal Stem Cell in Pulmonary Hemosiderosis Condición: Idiopathic Pulmonary Hemosiderosis Fecha: 2016-12-03 Intervenciones: Biological: Bone marrow mesenchymal stem cells in treatment of Idiopathic pulmonary hemosiderosis |
Completed |
Nombre del estudio: Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis Condición:
Fecha: 2008-02-27 Intervenciones: Drug: Deferasirox (ICL670) The recommended initial daily dose of Deferasirox is 20 mg/kg body weight. |
Completed |
Nombre del estudio: A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis Condición:
Fecha: 2005-09-12 Intervenciones: Drug: deferasirox |
Completed |
Nombre del estudio: Pharmacogenetic Study in Patients Received Iron Chelating Agent Condición: Hemosiderosis Fecha: 2012-06-12 |
Completed |
Nombre del estudio: Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to Food Condición: Transfusional Hemosiderosis Fecha: 2009-02-16 Intervenciones: Drug: deferasirox: deferasirox 20mg/kg/day unless on a higher dose at time of study entry. Crushed or di |
Completed |
Nombre del estudio: Safety, Tolerability, and Efficacy of Deferasirox in MDS Condición:
Fecha: 2007-05-03 Intervenciones: Drug: Deferasirox |
Completed |
Nombre del estudio: Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration) Condición:
Fecha: 2011-08-17 Intervenciones: Device: Non-contrast MRI Non-contrast MRI will be performed on each subject, at both 1.5T and 3.0T. Diff |
Completed |
Nombre del estudio: Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload Condición:
Fecha: 2008-01-14 Intervenciones: |